Clinical Trial Update: Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial of Patupilone in hormone-refractory prostate cancer (progressing after hormone therapy and docetaxel) has completed; no specific results are provi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Patupilone (epothilone B)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Hormone Refractory Prostate Cancer | Phase 2 | Status: COMPLETED